Sensient (SXT) Director Fee Deferral Recorded on Form 4
Rhea-AI Filing Summary
Insider transaction summary for Sensient Technologies (SXT): On 09/30/2025 director Deborah McKeithan Gebhardt reported changes in her beneficial ownership. The filing records a disposition of 16,332.571 shares of common stock and the acquisition by deferral of 87.187 units of deferred stock under the directors' deferred compensation plan. Deferred stock converts one-for-one into common shares and those 87.187 shares will be issued when her director service ends. The Form 4 was signed on 10/01/2025 by an attorney-in-fact. All items reflect director fee deferrals, restricted stock, and shares held in a dividend reinvestment plan as described in the explanations.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation deferral and a reported disposition; no material change to control or capital structure.
The Form 4 reflects a director electing to defer fees into deferred stock and reporting a disposal of 16,332.571 common shares on 09/30/2025. The 87.187 deferred-stock units convert one-for-one to common shares and are payable upon termination of board service. These are compensation-related transactions rather than open-market strategic trades, so they generally do not signal a change in corporate control or immediate dilution. The disclosure appears complete for the reported events.
TL;DR: Compensation deferral documented correctly; governance implications are routine and non-material.
The filing shows the director used the Issuer's Directors' Deferred Compensation Plan to defer fees into deferred stock and reports restricted-stock and dividend reinvestment holdings. The disclosure includes the mechanics (one-for-one conversion and issuance upon termination). From a governance perspective, these are standard director compensation arrangements with appropriate Form 4 reporting and no immediate governance concerns disclosed.